Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
January 8, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 30, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 13, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 14, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 15, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 28, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 16, 2024 8-K

Report of unscheduled material events or corporate event

View HTML
April 23, 2024 8-K

Report of unscheduled material events or corporate event

View HTML
March 12, 2014 8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

View HTML
February 10, 2017 5

Annual filing director officer or owner of more than ten percent.

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us